Unbound MEDLINE

Early intralipid therapy may have prevented bupivacaine-associated cardiac arrest. Regional anesthesia and pain medicine [Reg Anesth Pain Med] Journal article

 
McCutchen T, Gerancher JC 
Early intralipid therapy may have prevented bupivacaine-associated cardiac arrest. [Journal Article]
Reg Anesth Pain Med 2008 Mar-Apr; 33(2):178-80.


OBJECTIVE: Local anesthetic-induced cardiotoxicity remains a complication of regional anesthesia, with the potential to result in cardiac arrest refractory to resuscitation. Successful resuscitation using Intralipid (Baxter Pharmaceuticals by Fresenius Kabi, Uppsala, Sweden), has been reported in 2 patients with bupivacaine-induced cardiac arrest.
CASE REPORT: We report another case for which Intralipid was used as part of a successful resuscitation in a patient with local anesthetic-induced cardiotoxicity.
CONCLUSIONS: Early treatment with Intralipid may help prevent cardiac arrest and speed successful resuscitation efforts.



More from this journal
  
Advertise on this site.